1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING AGING POPULATION AND OBESITY
3.1.2. AWARENESS OF ILL EFFECTS OF UNTREATED SLEEP APNEA
3.1.3. SLEEP APNEA INCIDENCES
3.1.4. DEMAND FOR PORTABLE SLEEP APNEA DEVICES
3.1.5. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF SLEEP APNEA DEVICES
3.2.2. LACK OF REIMBURSEMENTS
3.2.3. DEARTH OF PATIENT COMPLIANCE

4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. REGULATORY FRAMEWORK
4.4.1. NORTH AMERICA
4.4.2. EUROPE
4.4.3. ASIA-PACIFIC
4.5. SUPPLY CHAIN ANALYSIS
4.6. OPPORTUNITY MATRIX
4.7. VENDOR LANDSCAPE

5. MARKET BY PRODUCT TYPE
5.1. THERAPEUTICS
5.1.1. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
5.1.1.1. CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES
5.1.1.2. BILEVEL POSITIVE AIRWAY PRESSURE (BPAP) DEVICES
5.1.2. OXYGEN DEVICES
5.1.2.1. OXYGEN CONCENTRATORS
5.1.2.2. PORTABLE OXYGEN CONCENTRATORS
5.1.2.3. LIQUID PORTABLE OXYGEN
5.1.3. MASKS AND ACCESSORIES
5.1.4. ORAL APPLIANCES
5.1.4.1. MANDIBULAR ADVANCEMENT DEVICES
5.1.4.2. TONGUE RETAINERS
5.1.5. ADAPTIVE SERVO VENTILATION (ASV) DEVICES
5.2. DIAGNOSTICS AND MONITORING
5.2.1. POLYSOMNOGRAPHY DEVICE (PSG)
5.2.1.1. CLINICAL PSG DEVICE
5.2.1.2. AMBULATORY PSG DEVICE
5.2.2. OXIMETER
5.2.2.1. TABLETOP OXIMETER
5.2.2.2. FINGERTIP OXIMETER
5.2.2.3. HANDHELD OXIMETER
5.2.2.4. WRIST-WORN OXIMETER
5.2.3. ACTIGRAPHY MONITORING DEVICE
5.2.4. RESPIRATORY POLYGRAPH
5.2.5. SLEEP APNEA SCREENING DEVICE
5.2.6. OTHER DIAGNOSTICS AND MONITORING DEVICES

6. MARKET BY END-USER
6.1. HOSPITALS & SLEEP LABORATORIES
6.2. HOME CARE SETTINGS

7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET SIZE & ESTIMATES
7.2.2. KEY GROWTH ENABLERS
7.2.3. KEY CHALLENGES
7.2.4. KEY PLAYERS
7.2.5. COUNTRY ANALYSIS
7.2.5.1. GERMANY
7.2.5.2. FRANCE
7.2.5.3. UNITED KINGDOM
7.2.5.4. ITALY
7.2.5.5. RUSSIA
7.2.5.6. BELGIUM
7.2.5.7. POLAND
7.2.5.8. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET SIZE & ESTIMATES
7.3.2. KEY GROWTH ENABLERS
7.3.3. KEY CHALLENGES
7.3.4. KEY PLAYERS
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. AUSTRALIA & NEW ZEALAND
7.3.5.4. INDIA
7.3.5.5. SOUTH KOREA
7.3.5.6. THAILAND
7.3.5.7. INDONESIA
7.3.5.8. VIETNAM
7.3.5.9. REST OF ASIA-PACIFIC
7.4. REST OF WORLD
7.4.1. MARKET SIZE & ESTIMATES
7.4.2. KEY GROWTH ENABLERS
7.4.3. KEY CHALLENGE
7.4.4. KEY PLAYERS
7.4.5. REGIONAL ANALYSIS
7.4.5.1. LATIN AMERICA
7.4.5.2. MIDDLE EAST & AFRICA

8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. BMC MEDICAL CO LTD
8.2.2. BRAEBON MEDICAL CORPORATION
8.2.3. CADWELL INDUSTRIES INC
8.2.4. DEVILBISS HEALTHCARE LLC
8.2.5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
8.2.6. GE HEALTHCARE
8.2.7. INVACARE CORPORATION
8.2.8. ITAMAR MEDICAL LTD
8.2.9. KONINKLIJKE PHILIPS NV
8.2.10. MEDTRONIC PLC
8.2.11. NIHON KOHDEN CORPORATION
8.2.12. RESMED INC
8.2.13. SMITHS MEDICAL INC
8.2.14. SOMNOMEDICS GMBH
8.2.15. TELEFLEX INCORPORATED
8.2.16. VYAIRE MEDICAL INC